Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ADA-011 / Adanate
NCT05601219: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors	Active, not recruiting	1	45	US	ADA-011, PD(L)-1 inhibitor	Adanate, Inc	Solid Tumor, Adult	10/24	12/24